Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. |
A) Cell purity |
Before separation | Label-free CD8 + cells | |
Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | |
B) Label-free cells: REAlease Biotin Complex release | ||
Before separation | MicroBead-free CD8 + cells | Label-free CD8 + cells |
Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. |
A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. |
A) Cell purity |
Before separation | Label-free CD8 + cells | |
Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | |
B) Label-free cells: REAlease Biotin Complex release | ||
Before separation | MicroBead-free CD8 + cells | Label-free CD8 + cells |
Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. | Figure 1A) CD8 + cells were isolated from a complete buffy coat using the StraightFrom ® Buffy Coat REAlease ® CD8 MicroBead Kit, Whole Blood Columns, and a MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity™ Antibodies CD8-APC and analyzed by flow cytometry using the MACSQuant ® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. B) The efficient removal of all labels was shown by using Biotin-APC-Vio ® 770 to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD8 + cells”), whereas the label-free CD8 + cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation. |
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.